Sutures Versus Polyglactin Mesh in Hiatal Hernia Repair
Launched by OULU UNIVERSITY HOSPITAL · Jan 19, 2022
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different methods for repairing a type of hernia called a paraesophageal hernia, which can cause symptoms like pain, heartburn, and in some cases, serious complications. The trial will compare using traditional sutures versus a special type of mesh called polyglactin (Vicryl®) to see which method better prevents the hernia from coming back after surgery. Researchers will enroll a total of 110 patients who are 18 years or older and are scheduled for laparoscopic surgery to fix this hernia. Participants will need to have a specific type of hernia confirmed by medical imaging or endoscopy, and they must be able to provide informed consent.
If you join this trial, you can expect to receive either the suture or mesh repair during your surgery. The main goal is to check for any recurrence of the hernia six months after the procedure using a specialized scan. Additionally, the study will look at other factors, like any recurring symptoms, the need for further surgeries, and how your quality of life might change over the next 20 years. This trial is currently recruiting participants of all genders, so if you or someone you know is dealing with this type of hernia and meets the eligibility criteria, it could be an opportunity to contribute to important research in this area.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Over 18 years old
- • Type III-IV PEH with either radiologic or endoscopic confirmation
- • Scheduled for laparoscopic PEH repair
- • The informed consent is acquired
- Exclusion Criteria:
- • Need for esophagus lengthening procedure (Collis gastroplasty)
- • Recurrent PEH
- • Emergency surgery
- • No written consent
About Oulu University Hospital
Oulu University Hospital is a leading academic medical center located in Oulu, Finland, dedicated to advancing healthcare through innovative clinical research and education. As a sponsor of clinical trials, the hospital leverages its robust infrastructure, interdisciplinary expertise, and commitment to patient-centered care to facilitate groundbreaking studies across various medical disciplines. By fostering collaboration between researchers, healthcare professionals, and patients, Oulu University Hospital aims to translate scientific discoveries into effective treatments and improve health outcomes, contributing to the global advancement of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Oulu, , Finland
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials